Direxion Daily TSLA Bull 1.5X Shares

ProShares UltraShort Bloomberg Natrl Gas

GraniteShares 1.5x Long NVDA Daily ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Bank Of Montreal

GraniteShares 1.25x Long Tesla Daily ETF

Direxion Daily S&P Biotech Bear 3X ETF

ProShares UltraShort Silver

Direxion Daily FTSE China Bull 3X ETF

VS TR 2x Long VIX Futures ETF

ProShares Ultra Bloomberg Natural Gas

Volatility Shares Trust 2x Ether ETF

T-REX 2X Inverse Tesla Daily Target ETF

MicroSectors Gold Miners 3X Leveraged ETN

ProShares Ultra Silver

United States Natural Gas

Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily Gold Miners Bull 3X ETF

iShares Ethereum Trust ETF

iShares US Home Construction

Incannex Healthcare Limited American Depositary Shares

Innovative Eyewear Inc. Common Stock

Septerna Inc. Common Stock

HWH International Inc. Common Stock

DevvStream Corp. Common Stock

Rigetti Computing Inc. Common Stock

ZK International Group Co. Ltd Ordinary Share

Super Micro Computer Inc. Common Stock

Oklo Inc.

EchoStar  Corporation Common Stock

Inno Holdings Inc. Common Stock

Gryphon Digital Mining Inc Common Stock

Next Technology Holding Inc. Ordinary Shares

Kindly MD Inc. Common Stock

Nuvve Holding Corp. Common Stock

Classover Holdings Inc. Class B Common Stock

Oriental Rise Holdings Limited Ordinary Shares

MicroAlgo Inc. Ordinary Shares

Hyperscale Data Inc. Common Stock

LQR House Inc. Common Stock

Click here to get full coverage on Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress - Stock Titan

Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress  Stock Titan

Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress - Stock Titan

Click here to get full coverage on AUTOLUS THERAPEUTICS Earnings Results: $AUTL Reports Quarterly Earnings - Nasdaq

AUTOLUS THERAPEUTICS Earnings Results: $AUTL Reports Quarterly Earnings  Nasdaq

AUTOLUS THERAPEUTICS Earnings Results: $AUTL Reports Quarterly Earnings - Nasdaq

Click here to get full coverage on Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2025 Earnings Call Transcript - Insider Monkey

Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2025 Earnings Call Transcript  Insider Monkey

Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Autolus Therapeutics (AUTL) Reports In-Line Q1 EPS - StreetInsider

Autolus Therapeutics (AUTL) Reports In-Line Q1 EPS  StreetInsider

Autolus Therapeutics (AUTL) Reports In-Line Q1 EPS - StreetInsider

Click here to get full coverage on Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now? - Yahoo Finance

Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now?  Yahoo Finance

Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now? - Yahoo Finance

Click here to get full coverage on Shareholders in Autolus Therapeutics (NASDAQ:AUTL) have lost 79%, as stock drops 11% this past week - simplywall.st

Shareholders in Autolus Therapeutics (NASDAQ:AUTL) have lost 79%, as stock drops 11% this past week  simplywall.st

Shareholders in Autolus Therapeutics (NASDAQ:AUTL) have lost 79%, as stock drops 11% this past week - simplywall.st

Click here to get full coverage on Syncona Portfolio Ltd Expands Stake in Autolus Therapeutics PLC - GuruFocus

Syncona Portfolio Ltd Expands Stake in Autolus Therapeutics PLC  GuruFocus

Syncona Portfolio Ltd Expands Stake in Autolus Therapeutics PLC - GuruFocus

Click here to get full coverage on Autolus Therapeutics Will Remain Depressed For A While (NASDAQ:AUTL) - Seeking Alpha

Autolus Therapeutics Will Remain Depressed For A While (NASDAQ:AUTL)  Seeking Alpha

Autolus Therapeutics Will Remain Depressed For A While (NASDAQ:AUTL) - Seeking Alpha

Click here to get full coverage on Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates - Stock Titan

Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates  Stock Titan

Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates - Stock Titan

Click here to get full coverage on Autolus Therapeutics plc (AUTL): A Bull Case Theory - Yahoo Finance

Autolus Therapeutics plc (AUTL): A Bull Case Theory  Yahoo Finance

Autolus Therapeutics plc (AUTL): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on Autolus Therapeutics (AUTL) Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblast - StreetInsider

Autolus Therapeutics (AUTL) Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblast  StreetInsider

Autolus Therapeutics (AUTL) Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblast - StreetInsider

Click here to get full coverage on Revolutionary Leukemia Treatment: Autolus's CAR-T Therapy Secures First-Ever UK Approval with 77% Success Rate - Stock Titan

Revolutionary Leukemia Treatment: Autolus's CAR-T Therapy Secures First-Ever UK Approval with 77% Success Rate  Stock Titan

Revolutionary Leukemia Treatment: Autolus's CAR-T Therapy Secures First-Ever UK Approval with 77% Success Rate - Stock Titan

Click here to get full coverage on Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts - Yahoo Finance

Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts  Yahoo Finance

Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts - Yahoo Finance

Click here to get full coverage on Autolus Therapeutics CEO Takes Center Stage at Major Healthcare Conference: Key Updates Expected - Stock Titan

Autolus Therapeutics CEO Takes Center Stage at Major Healthcare Conference: Key Updates Expected  Stock Titan

Autolus Therapeutics CEO Takes Center Stage at Major Healthcare Conference: Key Updates Expected - Stock Titan

Click here to get full coverage on Autolus to Unveil New Lupus Trial Data and Pipeline Expansion Plans at R&D Event - Stock Titan

Autolus to Unveil New Lupus Trial Data and Pipeline Expansion Plans at R&D Event  Stock Titan

Autolus to Unveil New Lupus Trial Data and Pipeline Expansion Plans at R&D Event - Stock Titan

Click here to get full coverage on Autolus Clinical Trial Shows Breakthrough 50% Response in Lupus Patients, Plans MS Treatment Launch - Stock Titan

Autolus Clinical Trial Shows Breakthrough 50% Response in Lupus Patients, Plans MS Treatment Launch  Stock Titan

Autolus Clinical Trial Shows Breakthrough 50% Response in Lupus Patients, Plans MS Treatment Launch - Stock Titan

Click here to get full coverage on Major Governance Overhaul: Innate Pharma Strengthens Leadership with Strategic Board Restructuring - Stock Titan

Major Governance Overhaul: Innate Pharma Strengthens Leadership with Strategic Board Restructuring  Stock Titan

Major Governance Overhaul: Innate Pharma Strengthens Leadership with Strategic Board Restructuring - Stock Titan

Click here to get full coverage on When Will Autolus Report Q4 Earnings? Key Date for Cell Therapy Leader - Stock Titan

When Will Autolus Report Q4 Earnings? Key Date for Cell Therapy Leader  Stock Titan

When Will Autolus Report Q4 Earnings? Key Date for Cell Therapy Leader - Stock Titan

Click here to get full coverage on Autolus Therapeutics Q1 Earnings Preview: Key T Cell Therapy Commercial Updates Expected May 8 - Stock Titan

Autolus Therapeutics Q1 Earnings Preview: Key T Cell Therapy Commercial Updates Expected May 8  Stock Titan

Autolus Therapeutics Q1 Earnings Preview: Key T Cell Therapy Commercial Updates Expected May 8 - Stock Titan

Click here to get full coverage on Further weakness as Autolus Therapeutics (NASDAQ:AUTL) drops 21% this week, taking five-year losses to 71% - Yahoo Finance

Further weakness as Autolus Therapeutics (NASDAQ:AUTL) drops 21% this week, taking five-year losses to 71%  Yahoo Finance

Further weakness as Autolus Therapeutics (NASDAQ:AUTL) drops 21% this week, taking five-year losses to 71% - Yahoo Finance

Click here to get full coverage on Industry Analysts Just Upgraded Their Autolus Therapeutics plc (NASDAQ:AUTL) Revenue Forecasts By 12% - simplywall.st

Industry Analysts Just Upgraded Their Autolus Therapeutics plc (NASDAQ:AUTL) Revenue Forecasts By 12%  simplywall.st

Industry Analysts Just Upgraded Their Autolus Therapeutics plc (NASDAQ:AUTL) Revenue Forecasts By 12% - simplywall.st

Click here to get full coverage on Autolus Therapeutics: Beaten Down, Cash Rich, Poised To Launch A CAR-T Cell Therapy (NASDAQ:AUTL) - Seeking Alpha

Autolus Therapeutics: Beaten Down, Cash Rich, Poised To Launch A CAR-T Cell Therapy (NASDAQ:AUTL)  Seeking Alpha

Autolus Therapeutics: Beaten Down, Cash Rich, Poised To Launch A CAR-T Cell Therapy (NASDAQ:AUTL) - Seeking Alpha

Click here to get full coverage on Autolus Therapeutics plc (AUTL): The Best Multibagger Penny Stock of 2025? - Yahoo Finance

Autolus Therapeutics plc (AUTL): The Best Multibagger Penny Stock of 2025?  Yahoo Finance

Autolus Therapeutics plc (AUTL): The Best Multibagger Penny Stock of 2025? - Yahoo Finance

Click here to get full coverage on Is Autolus Therapeutics (NASDAQ:AUTL) A Risky Investment? - simplywall.st

Is Autolus Therapeutics (NASDAQ:AUTL) A Risky Investment?  simplywall.st

Is Autolus Therapeutics (NASDAQ:AUTL) A Risky Investment? - simplywall.st

Click here to get full coverage on AUTL stock touches 52-week low at $1.53 amid market challenges - Investing.com

AUTL stock touches 52-week low at $1.53 amid market challenges  Investing.com

AUTL stock touches 52-week low at $1.53 amid market challenges - Investing.com

Click here to get full coverage on Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Report Preview: What to Expect - GuruFocus

Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Report Preview: What to Expect  GuruFocus

Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Report Preview: What to Expect - GuruFocus

Click here to get full coverage on Analysts Offer Insights on Healthcare Companies: Encompass Health (EHC), Autolus Therapeutics (AUTL) and PROCEPT BioRobotics (PRCT) - The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Encompass Health (EHC), Autolus Therapeutics (AUTL) and PROCEPT BioRobotics (PRCT)  The Globe and Mail

Analysts Offer Insights on Healthcare Companies: Encompass Health (EHC), Autolus Therapeutics (AUTL) and PROCEPT BioRobotics (PRCT) - The Globe and Mail

Click here to get full coverage on Autolus Therapeutics (AUTL) Secures U.K. Approval for CAR-T Therapy Aucatzyl | AUTL Stock News - GuruFocus

Autolus Therapeutics (AUTL) Secures U.K. Approval for CAR-T Therapy Aucatzyl | AUTL Stock News  GuruFocus

Autolus Therapeutics (AUTL) Secures U.K. Approval for CAR-T Therapy Aucatzyl | AUTL Stock News - GuruFocus

Click here to get full coverage on AUTL stock touches 52-week low at $1.87 amid market challenges - Investing.com

AUTL stock touches 52-week low at $1.87 amid market challenges  Investing.com

AUTL stock touches 52-week low at $1.87 amid market challenges - Investing.com

Click here to get full coverage on Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates - TradingView

Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates  TradingView

Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates - TradingView

Click here to get full coverage on AUCATZYL's Approval Positions Autolus Therapeutics Favorably In The CAR-T Market - Seeking Alpha

AUCATZYL's Approval Positions Autolus Therapeutics Favorably In The CAR-T Market  Seeking Alpha

AUCATZYL's Approval Positions Autolus Therapeutics Favorably In The CAR-T Market - Seeking Alpha

Click here to get full coverage on Autolus Therapeutics earnings matched, revenue topped estimates - Investing.com

Autolus Therapeutics earnings matched, revenue topped estimates  Investing.com

Autolus Therapeutics earnings matched, revenue topped estimates - Investing.com

Click here to get full coverage on Is Autolus Therapeutics plc (AUTL) the Best UK Growth Stock to Buy Now? - Insider Monkey

Is Autolus Therapeutics plc (AUTL) the Best UK Growth Stock to Buy Now?  Insider Monkey

Is Autolus Therapeutics plc (AUTL) the Best UK Growth Stock to Buy Now? - Insider Monkey

Click here to get full coverage on Autolus Therapeutics Reports Q1 2025 Financial Results - TipRanks

Autolus Therapeutics Reports Q1 2025 Financial Results  TipRanks

Autolus Therapeutics Reports Q1 2025 Financial Results - TipRanks

Click here to get full coverage on Autolus: Start Thinking About Obe-Cel PDUFA -- And The (Baby) Bull Case - Seeking Alpha

Autolus: Start Thinking About Obe-Cel PDUFA -- And The (Baby) Bull Case  Seeking Alpha

Autolus: Start Thinking About Obe-Cel PDUFA -- And The (Baby) Bull Case - Seeking Alpha

Click here to get full coverage on Autolus Therapeutics to Announce Q1 2025 Financial Results and Host Conference Call on May 8 - Nasdaq

Autolus Therapeutics to Announce Q1 2025 Financial Results and Host Conference Call on May 8  Nasdaq

Autolus Therapeutics to Announce Q1 2025 Financial Results and Host Conference Call on May 8 - Nasdaq

Click here to get full coverage on Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - TradingView

Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025  TradingView

Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - TradingView

Click here to get full coverage on Autolus Therapeutics plc SEC 10-K Report - TradingView

Autolus Therapeutics plc SEC 10-K Report  TradingView

Autolus Therapeutics plc SEC 10-K Report - TradingView

Click here to get full coverage on Autolus Therapeutics Announces Leadership Transition in Finance - TipRanks

Autolus Therapeutics Announces Leadership Transition in Finance  TipRanks

Autolus Therapeutics Announces Leadership Transition in Finance - TipRanks

Click here to get full coverage on Autolus reports $9M in Q1 product revenue, gains UK approval - Investing.com Nigeria

Autolus reports $9M in Q1 product revenue, gains UK approval  Investing.com Nigeria

Autolus reports $9M in Q1 product revenue, gains UK approval - Investing.com Nigeria

Click here to get full coverage on Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2024 Earnings Call Transcript - Insider Monkey

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2024 Earnings Call Transcript  Insider Monkey

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2024 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on Autolus Therapeutics Third Quarter 2024 Earnings: US$0.31 loss per share (vs US$0.26 loss in 3Q 2023) - Yahoo Finance

Autolus Therapeutics Third Quarter 2024 Earnings: US$0.31 loss per share (vs US$0.26 loss in 3Q 2023)  Yahoo Finance

Autolus Therapeutics Third Quarter 2024 Earnings: US$0.31 loss per share (vs US$0.26 loss in 3Q 2023) - Yahoo Finance

Click here to get full coverage on 12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session  Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Click here to get full coverage on Autolus Therapeutics to Present R&D Update April 23 - TipRanks

Autolus Therapeutics to Present R&D Update April 23  TipRanks

Autolus Therapeutics to Present R&D Update April 23 - TipRanks

Click here to get full coverage on Autolus reports $9M in Q1 product revenue, gains UK approval By Investing.com - Investing.com South Africa

Autolus reports $9M in Q1 product revenue, gains UK approval By Investing.com  Investing.com South Africa

Autolus reports $9M in Q1 product revenue, gains UK approval By Investing.com - Investing.com South Africa

Click here to get full coverage on AUTL stock touches 52-week low at $1.53 amid market challenges - Investing.com Canada

AUTL stock touches 52-week low at $1.53 amid market challenges  Investing.com Canada

AUTL stock touches 52-week low at $1.53 amid market challenges - Investing.com Canada

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Autolus Therapeutics Gains FDA Approval for AUCATZYL - TipRanks

Autolus Therapeutics Gains FDA Approval for AUCATZYL  TipRanks

Autolus Therapeutics Gains FDA Approval for AUCATZYL - TipRanks

Click here to get full coverage on Autolus reports $9M in Q1 product revenue, gains UK approval - Investing.com Australia

Autolus reports $9M in Q1 product revenue, gains UK approval  Investing.com Australia

Autolus reports $9M in Q1 product revenue, gains UK approval - Investing.com Australia

Click here to get full coverage on Autolus Therapeutics earnings matched, revenue topped estimates By Investing.com - Investing.com UK

Autolus Therapeutics earnings matched, revenue topped estimates By Investing.com  Investing.com UK

Autolus Therapeutics earnings matched, revenue topped estimates By Investing.com - Investing.com UK

Click here to get full coverage on 10 Best Fast-Growing Penny Stocks to Buy Now - Insider Monkey

10 Best Fast-Growing Penny Stocks to Buy Now  Insider Monkey

10 Best Fast-Growing Penny Stocks to Buy Now - Insider Monkey

Click here to get full coverage on Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - The Manila Times

Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025  The Manila Times

Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - The Manila Times

Click here to get full coverage on Autolus Therapeutics Reports Strong 2024 Results - TipRanks

Autolus Therapeutics Reports Strong 2024 Results  TipRanks

Autolus Therapeutics Reports Strong 2024 Results - TipRanks

Click here to get full coverage on Autolus Therapeutics Provides Business Updates and 2025 Overview - The Manila Times

Autolus Therapeutics Provides Business Updates and 2025 Overview  The Manila Times

AUTL

Price Chart

Key Statistics

Technicals

About AUTL

Latest News

Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress - Stock Titan

AUTOLUS THERAPEUTICS Earnings Results: $AUTL Reports Quarterly Earnings - Nasdaq

Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2025 Earnings Call Transcript - Insider Monkey

Advanced Charts

Top Gainers

Top Losers